You are viewing the site in preview mode

Skip to main content

Table 2 Course of laboratory tests over time in patient 2

From: Successful treatment of refractory hyperferritinemic syndromes with canakinumab: a report of two cases

Days from admission at Authors’ center -4 0 + 20 + 30 + 35a + 40 + 50
White blood cells (×103/mm3) 14.2 10.6 3.4 5.4 3.7 18.9 5.5
Neutrophil count (× 103/mm3) 11.9 6.6 1.9 3.4 1.7 15.1 2.9
Hemoglobin (g/dL) 9.2 11.2 10.8 10.8 10.5 9.9 11.1
Platelet count (×103/mm3) 285 424 105 233 145 164 253
Erythrocyte sedimentation rate (mm/h) 75 68 43 55 63 50 36
C-reactive protein (mg/dL) 2.5 <  0.46 1.83 < 0.46 0.6 <  0.46 <  0.46
Aspartate aminotransferase (U/L) 61 40 350 111 113 35 31
Lactate dehydrogenase (U/L) 1673 1048 4960 1541 2122 1116 468
Triglycerides (mg/dL) 209 173 273 – 157 – –
Fibrinogen (mg/dL) 356 418 234 297 424 312 267
Ferritin (ng/mL) 20,350 5065 49,700 17,580 28,634 12,340 201
  1. aStart of canakinumab administration
Back to article page

Pediatric Rheumatology

ISSN: 1546-0096